To read the full story, subscribe or sign in.

NN-42-1007: First potent and selective hepatic glycogen phosphorylase inhibitor

June 7, 1996

No Comments

BioWorld Science Conferences New compound Endocrine/metabolic

Today's news in brief

BioWorld

BioWorld briefs for Nov. 22, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for November 21, 2024.

J&J’s Ottava robotic system approved for US pivotal trial

BioWorld MedTech

Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes...

‘Evo’ AI can design complete genomes

BioWorld Science

The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...

Endoflip system with display and catheter

Medtronic receives CE mark for next generation Endoflip system

BioWorld MedTech

Medtronic plc obtained a CE mark for its next generation Endoflip 300 system which measures pressure and dimensions in the esophagus and pylorus, in adults. The...